Ketoprofen — products, DINs, and Canadian availability
This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Ketoprofen. We track 47 distinct Drug Identification Numbers (DINs) for this molecule, of which 7 are currently in marketed status. Across those registrations there are 17 manufacturers or marketing authorization holders, 7 dosage forms, and 7 distinct strength presentations.
Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Ketoprofen in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.
Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Ketoprofen product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.
Dosage forms and strengths recorded for Ketoprofen
Dosage forms: Solution, Tablet, Capsule, Tablet (Extended-Release), Suppository, Tablet (Enteric-Coated), Capsule (Sustained-Release). Strengths: 100 MG, 10 MG, 20 MG, 5 MG, 50 MG, 200 MG, 150 MG.
Manufacturers and marketing authorization holders
BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC., MERIAL CANADA INC, ZOETIS CANADA INC, BIMEDA-MTC ANIMAL HEALTH INC, AA PHARMA INC, PHARMEL INC, MODERN VETERINARY THERAPEUTICS LLC, PRO DOC LIMITEE, NOVOPHARM LIMITED, NU-PHARM INC, TECHNILAB PHARMA INC., AVENTIS PHARMA INC, PHARMASCIENCE INC, SANOFI-AVENTIS CANADA INC, RHODIAPHARM INC, VETVIVA RICHTER GMBH, TEVA CANADA LIMITED.
Registered products containing Ketoprofen
| DIN | Product | Manufacturer | Strength | Dosage form | Status |
|---|---|---|---|---|---|
| 01938126 | ANAFEN | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | 100 MG | Solution | Cancelled Post Market |
| 02150999 | ANAFEN INJECTION 10MG/ML | MERIAL CANADA INC | 10 MG | Solution | Cancelled Post Market |
| 02150972 | ANAFEN TABLETS 10MG/TAB | MERIAL CANADA INC | 10 MG | Tablet | Cancelled Post Market |
| 02150980 | ANAFEN TABLETS 20MG/TAB | MERIAL CANADA INC | 20 MG | Tablet | Cancelled Post Market |
| 02150964 | ANAFEN TABLETS 5MG/TAB | MERIAL CANADA INC | 5 MG | Tablet | Cancelled Post Market |
| 02516683 | DRAXXIN KP | ZOETIS CANADA INC | 100 MG | Solution | Marketed |
| 02534606 | FARMAFEN | BIMEDA-MTC ANIMAL HEALTH INC | 100 MG | Solution | Marketed |
| 00790427 | KETOPROFEN | AA PHARMA INC | 50 MG | Capsule | Dormant |
| 02172577 | KETOPROFEN SR | AA PHARMA INC | 200 MG | Tablet (Extended-Release) | Marketed |
| 02236965 | KETOPROFEN SUPPOSITORIES | PHARMEL INC | 50 MG | Suppository | Cancelled Pre Market |
| 02237011 | KETOPROFEN SUPPOSITORIES | PHARMEL INC | 100 MG | Suppository | Cancelled Post Market |
| 02446316 | KETOPROFEN V | MODERN VETERINARY THERAPEUTICS LLC | 100 MG | Solution | Marketed |
| 00842664 | KETOPROFEN-E | AA PHARMA INC | 100 MG | Tablet (Enteric-Coated) | Marketed |
| 00790435 | KETOPROFEN-E | AA PHARMA INC | 50 MG | Tablet (Enteric-Coated) | Marketed |
| 02084198 | KETOPROFEN-E ECT 100MG | PRO DOC LIMITEE | 100 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 02084171 | KETOPROFEN-E ECT 50MG | PRO DOC LIMITEE | 50 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 02210487 | KETOPROFEN-SR - SRT 200MG | PRO DOC LIMITEE | 200 MG | Tablet (Extended-Release) | Cancelled Post Market |
| 02156083 | NOVO-KETO SUPPOSITORIES 100MG | NOVOPHARM LIMITED | 100 MG | Suppository | Cancelled Post Market |
| 01981536 | NOVO-KETO-EC TAB 100MG | NOVOPHARM LIMITED | 100 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 01981528 | NOVO-KETO-EC TAB 50MG | NOVOPHARM LIMITED | 50 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 02044633 | NU-KETOPROFEN CAP 50MG | NU-PHARM INC | 50 MG | Capsule | Cancelled Post Market |
| 02044641 | NU-KETOPROFEN-E ECT 100MG | NU-PHARM INC | 100 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 02044781 | NU-KETOPROFEN-E ECT 50MG | NU-PHARM INC | 50 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 02165481 | ORAFEN - SUP RT 100MG | TECHNILAB PHARMA INC. | 100 MG | Suppository | Cancelled Post Market |
| 01926411 | ORUDIS 100 | AVENTIS PHARMA INC | 100 MG | Suppository | Cancelled Post Market |
| 01931512 | ORUDIS 50 | AVENTIS PHARMA INC | 50 MG | Suppository | Cancelled Post Market |
| 01926403 | ORUDIS CAP 50MG | AVENTIS PHARMA INC | 50 MG | Capsule | Cancelled Post Market |
| 01926365 | ORUDIS E-100 | AVENTIS PHARMA INC | 100 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 01926381 | ORUDIS E-50 | AVENTIS PHARMA INC | 50 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 01926373 | ORUDIS SR-200 | AVENTIS PHARMA INC | 200 MG | Tablet (Extended-Release) | Cancelled Post Market |
| 01913050 | ORUVAIL 150 | AVENTIS PHARMA INC | 150 MG | Capsule (Sustained-Release) | Cancelled Post Market |
| 01913069 | ORUVAIL 200 | AVENTIS PHARMA INC | 200 MG | Capsule (Sustained-Release) | Cancelled Post Market |
| 02015951 | PMS-KETOPROFEN | PHARMASCIENCE INC | 100 MG | Suppository | Cancelled Post Market |
| 02148773 | PMS-KETOPROFEN | PHARMASCIENCE INC | 50 MG | Suppository | Cancelled Post Market |
| 02150808 | PMS-KETOPROFEN CAPSULES | PHARMASCIENCE INC | 50 MG | Capsule | Cancelled Post Market |
| 02150824 | PMS-KETOPROFEN E-100 - ECT | PHARMASCIENCE INC | 100 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 02150816 | PMS-KETOPROFEN E-50 - ECT 50MG | PHARMASCIENCE INC | 50 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 00761699 | RHODIS | SANOFI-AVENTIS CANADA INC | 100 MG | Suppository | Cancelled Post Market |
| 00761664 | RHODIS CAP 50MG | RHODIAPHARM INC | 50 MG | Capsule | Cancelled Post Market |
| 00761672 | RHODIS EC | SANOFI-AVENTIS CANADA INC | 50 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 00761680 | RHODIS EC | SANOFI-AVENTIS CANADA INC | 100 MG | Tablet (Enteric-Coated) | Cancelled Post Market |
| 02031175 | RHODIS SR 200MG | RHODIAPHARM INC | 200 MG | Tablet (Extended-Release) | Cancelled Post Market |
| 02183099 | RHOVAIL 150 | RHODIAPHARM INC | 150 MG | Capsule (Sustained-Release) | Cancelled Post Market |
| 02183102 | RHOVAIL 200 | RHODIAPHARM INC | 200 MG | Capsule (Sustained-Release) | Cancelled Post Market |
| 02519801 | RIFEN | VETVIVA RICHTER GMBH | 100 MG | Solution | Marketed |
| 02245966 | TEVA-KETOPROFEN | TEVA CANADA LIMITED | 5 MG | Tablet | Cancelled Post Market |
| 02245967 | TEVA-KETOPROFEN | TEVA CANADA LIMITED | 20 MG | Tablet | Cancelled Post Market |
Sourcing Ketoprofen through a licensed wholesaler
Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Ketoprofen we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.
Request a quote
Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for Ketoprofen and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.
Request a sourcing quote or call +1 (431) 588-9055.